GENEVA, July 6 -- CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/145842) for “NEW PROTEIN A LIGAND MUTANT AND USE THEREOF”. With publication no. WO/2026/139005, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 1/22
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....